Third Security’s Theriva Biologics TOVX Stock Holding History

Third Security’s Portfolio TOVX Stock Details TOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,513	Closed	-$256K	–	12
2019 Q1	$256K	Hold	1,513	–	–	0.04%	12
2018 Q4	$212K	Hold	1,513	–	–	0.03%	15
2018 Q3	$983K	Hold	1,513	–	–	0.06%	14
2018 Q2	$3.16M	Hold	1,513	–	–	0.25%	11
2018 Q1	$4.21M	Hold	1,513	–	–	0.31%	9
2017 Q4	$6.73M	Hold	1,513	–	–	0.58%	7
2017 Q3	$12.4M	Hold	1,513	–	–	0.78%	8
2017 Q2	$7.49M	Hold	1,513	–	–	0.38%	8
2017 Q1	$8.35M	Hold	1,513	–	–	0.49%	8
2016 Q4	$10.1M	Hold	1,513	–	–	0.54%	7
2016 Q3	$22.8M	Hold	1,513	–	–	1.06%	5
2016 Q2	$23.8M	Hold	1,513	–	–	1.24%	6
2016 Q1	$31.2M	Hold	1,513	–	–	1.22%	6
2015 Q4	$30.3M	Hold	1,513	–	–	1.21%	5
2015 Q3	$30.1M	Buy	1,513 +107	+8%	+$2.63M	1.2%	5
2015 Q2	$35.1M	Hold	1,406	–	–	0.92%	5
2015 Q1	$26.9M	Hold	1,406	–	–	0.76%	6
2014 Q4	$18M	Hold	1,406	–	–	0.82%	9
2014 Q3	$21.9M	Hold	1,406	–	–	1.37%	8
2014 Q2	$21.2M	Hold	1,406	–	–	1.01%	9
2014 Q1	$31.6M	Hold	1,406	–	–	1.4%	5
2013 Q4	$18.8M	Buy	1,406 +286	+26%	+$3.61M	0.9%	9
2013 Q3	$16.5M	Hold	1,120	–	–	0.84%	9
2013 Q2	$16.9M	Buy	+1,120	New	+$15.3M	4.03%	7

Other funds holding TOVX

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Third Security's TOVX Position: Q2 2019 in Review

Third Security sold out of Theriva Biologics (TOVX) in Q2 2019, closing a stake of 1,513 shares — an estimated $256K sold.

Third Security first reported a position in TOVX in Q2 2013 and held it in 24 quarters. The position peaked at $35.1M in Q2 2015. 18 funds tracked by Wall St. Rank hold TOVX as of Q2 2019.

Third Security reported no remaining Theriva Biologics position as of Q2 2019 after selling out during the quarter.
Third Security sold 1,513 Theriva Biologics shares in Q2 2019, an estimated $256K.
Third Security first reported a position in Theriva Biologics in Q2 2013 and held it in 24 quarters.
Third Security's Theriva Biologics position peaked at $35.1M in Q2 2015.
18 funds tracked by Wall St. Rank held Theriva Biologics as of Q2 2019.

Based on Third Security's 13F filing for Q2 2019, filed 9 Aug 2019.